Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Scheindlin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Molecular Interventions|August 27, 2005
A century of ulcer medicinesStanley Scheindlin
Molecular Interventions|March 2, 2006
When she says yes, but he needs no: some reflections on nitric oxideStanley Scheindlin
The New England Journal of Medicine|November 22, 2002
Chronic urticaria and angioedemaStanley Scheindlin
Molecular Interventions|July 14, 2009
The problematic placeboStanley Scheindlin
Molecular Interventions|September 9, 2006
Rare diseases, orphan drugs, and orphaned patientsStanley Scheindlin
Molecular Interventions|March 7, 2007
Clinical enzymology: enzymes as medicineStanley Scheindlin
Molecular Interventions|May 1, 2007
Medicine in the days of the caliphsStanley Scheindlin
Molecular Interventions|March 3, 2004
Ephedra: once a boon, now a baneStanley Scheindlin
Molecular Interventions|August 12, 2004
Demystifying the new drug applicationStanley Scheindlin
Molecular Interventions|January 16, 2009
Something old... something blueStanley Scheindlin
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Molecular Interventions|August 27, 2005
A century of ulcer medicinesStanley Scheindlin
Molecular Interventions|March 2, 2006
When she says yes, but he needs no: some reflections on nitric oxideStanley Scheindlin
The New England Journal of Medicine|November 22, 2002
Chronic urticaria and angioedemaStanley Scheindlin
Molecular Interventions|July 14, 2009
The problematic placeboStanley Scheindlin
Molecular Interventions|September 9, 2006
Rare diseases, orphan drugs, and orphaned patientsStanley Scheindlin
Molecular Interventions|March 7, 2007
Clinical enzymology: enzymes as medicineStanley Scheindlin
Molecular Interventions|May 1, 2007
Medicine in the days of the caliphsStanley Scheindlin
Molecular Interventions|March 3, 2004
Ephedra: once a boon, now a baneStanley Scheindlin
Molecular Interventions|August 12, 2004
Demystifying the new drug applicationStanley Scheindlin
Molecular Interventions|January 16, 2009
Something old... something blueStanley Scheindlin
Pageof 3